Ipilimumab/nivolumabHypophysitis: 25 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1859卷 / 1期

关键词：

D O I：

10.1007/s40278-021-97293-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：197 / 197

相关论文

共 50 条

[41] Ipilimumab/nivolumabColitis: 2 case reports
[J]. Reactions Weekly, 2019, 1735 (1) : 160 - 160
[42] Ipilimumab/pembrolizumabHypophysitis: 10 case reports
[J]. Reactions Weekly, 2015, 1576 (1) : 162 - 162
[43] Ipilimumab/nivolumabPneumonitis: 2 case reports
[J]. Reactions Weekly, 2020, 1787 (1) : 305 - 305
[44] Ipilimumab/nivolumabEncephalitis: 6 case reports
[J]. Reactions Weekly, 2017, 1665 (1) : 163 - 163
[45] Ipilimumab/nivolumabEnterocolitis: 7 case reports
[J]. Reactions Weekly, 2017, 1655 (1) : 148 - 148
[46] Ipilimumab/pembrolizumabHypophysitis: 2 case reports
[J]. Reactions Weekly, 2018, 1714 (1) : 242 - 242
[47] Ipilimumab/nivolumabColitis: 2 case reports
[J]. Reactions Weekly, 2020, 1788 (1) : 135 - 135
[48] Ipilimumab/nivolumabHepatitis: 2 case reports
[J]. Reactions Weekly, 2017, 1665 (1) : 164 - 164
[49] Ipilimumab/nivolumabPneumonitis: 20 case reports
[J]. Reactions Weekly, 2017, 1636 (1) : 182 - 182
[50] Ipilimumab/nivolumabColitis: 3 case reports
[J]. Reactions Weekly, 2022, 1928 (1) : 213 - 213

← 1 2 3 4 5 →